The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vasileva A.V.

Bekhterev National Research Medical Center for Psychiatry and Neurology;
Mechnikov North-Western State Medical University

Pandemic COVID-19 and mental disorders international experience and therapeutic approaches

Authors:

Vasileva A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(9): 121‑129

DOI: 10.17116/jnevro2020120091121

Views: 13552

Downloaded: 791

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Vasileva AV. Pandemic COVID-19 and mental disorders international experience and therapeutic approaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(9):121‑129. (In Russ.)
https://doi.org/10.17116/jnevro2020120091121

 
МСФ на ЯМ
Close metadata
Recommended articles:
The effect of inso­mnia on mild cognitive impairment in patients with vascular risks: resu­lts of a three-year longitudinal study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):30-36
A perspective on the application of CRISPR/CAS9 genome editing system to study of mole­cular-genetic basis of mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):27-33
Vali­dation of screening method based on EEG analysis for the risk asse­ssment of psychiatric and beha­vioral diso­rders: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):88-96
A clinical case of the new-onset bipo­lar affe­ctive diso­rder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129
Pathogenetic basis of modern approaches to the therapy of sleep diso­rders in the clinic of depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):69-74
Features of the clinical picture of affe­ctive diso­rders in women during the meno­pausal transition and early postmenopause. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):75-79
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
Impact of the COVID-19 epidemic on students health. Part 1. Health quality and life­style of technical universities’ students before and after the COVID-19 epidemic. Russian Journal of Preventive Medi­cine. 2024;(3):59-65
Variability of death rates from respiratory diseases in the regions of the Russian Fede­ration during the COVID-19 pandemic and the three previous years. Russian Journal of Preventive Medi­cine. 2024;(4):82-88
Life quality of universities’ students during COVID-19 pandemic. Russian Journal of Preventive Medi­cine. 2024;(5):92-96

The article considers the COVID-19 pandemic impact on the population mental health, the main psychogenic and somatogenic mental disorders associated with COVID-19 are distinguished. The comorbid PTSD clinical features are described. The mental health risk factors for health workers are presented. The psychotherapeutic and psychopharmaceutical approaches are proposed.

Keywords:

pandemic
coronavirus
anxiety
PTSD
depression
psychotherapy
tranquillizers
antidpepressants

Authors:

Vasileva A.V.

Bekhterev National Research Medical Center for Psychiatry and Neurology;
Mechnikov North-Western State Medical University

Received:

03.08.2020

Accepted:

28.08.2020

List of references:

  1. Boyko OM, Medvedeva TI, Enikolopov SN, Vorontsova OYu, Kazmina OYu. The psychological state of people during the COVID-19 pandemic and the target of psychological work. Psihologicheskie issledovanija. 2020;13(70):1. (In Russ.). https://psystudy.ru
  2. WHO Immunizing the public against misinformation. https://www.who.int/news-room/feature-stories/detail/immunizing-the-public-against-misinformation
  3. Tkhostov ASh, Rasskazova EI. Psychological contents of anxiety and the prevention in an infodemic situation: protection against coronavirus or the «vicious circle» of anxiety? Konsul’tativnaja psihologija i psihoterapija. 2020;28(2):70-89. (In Russ.). https://doi.org/10.17759/cpp.2020280204
  4. 1-ja konferencija VOZ po infodemiologii. (In Russ.). https://www.who.int/ru/news-room/events/detail/2020/06/30/default-calendar/1st-who-infodemiology-conference
  5. Sorokin MYu, Kasyanov ED, Rukavishnikov GV, Makarevich OV, Neznanov NG, Lutova NB, Mazo GE. Psychological reactions of the population as a factor of adaptation to the COVID-19 pandemic. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Behtereva. 2020;2:87-94. (In Russ.). https://doi.org/10.31363/2313-7053-2020-2-87-94
  6. Rasskazova EI, Leontiev DA, Lebedeva AA. Pandemic as a challenge to subjective well-being: anxiety and coping. Konsul’tativnaja psihologija i psihoterapija. 2020;28(2):90-108. (In Russ.). https://doi.org/10.17759/cpp.2020280205
  7. Karavaeva TA, Vasileva AV, Poltorak SV, Mizinova EB, Belan RM. Anxiety-phobic disorders criteria and diagnostic algorithm. V.M. Bekhterev review of psychiatry and medical psychology. 2015;4:117-122. (In Russ.).
  8. Karavaeva TA, Vasileva AV, Poltorak SV, Chekhlaty EI, Lukoshkina EP. Generalized anxiety disorder criteria and diagnostic algorithm. V.M. Bekhterev review of psychiatry and medical psychology. 2015;3:124-130. (In Russ.).
  9. Liu CH, Zhang E, Wong GTF, Hyun S, Hahm HC. Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: Clinical implications for U.S. young adult mental health (published online ahead of print, 2020 Jun 1). Psychiatry Res. 2020;290:113172. https://doi.org/10.1016/j.psychres.2020.113172
  10. Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis (published 2020 Jul 6). Global Health. 2020;16(1):57.  https://doi.org/10.1186/s12992-020-00589-w
  11. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence (published online ahead of print, 2020 May 30). Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.05.048
  12. Asmundson GJG, Taylor S. (2020). Coronaphobia: Fear and the 2019-nCoV outbreak. Journal of Anxiety Disorders. 2020;70.  https://doi.org/10.1016/j.janxdis.2020.102196
  13. Lee SA, Jobe MC, Mathis AA, Gibbons JA. Incremental validity of coronaphobia: Coronavirus anxiety explains depression, generalized anxiety, and death anxiety (epub ahead of print). J Anxiety Disord. 2020;74:102268. PMID: 32650221; PMCID: PMC7328548. https://doi.org/10.1016/j.janxdis.2020.102268
  14. Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7(3):228-229.  https://doi.org/10.1016/S2215-0366(20)30046-8
  15. Inchausti F, MacBeth A, Hasson-Ohayon I, Dimaggio G. Psychological Intervention and COVID-19: What We Know So Far and What We Can Do (published online ahead of print, 2020 May 27). J Contemp Psychother. 2020;1-8.  https://doi.org/10.1007/s10879-020-09460-w
  16. Bareket-Bojmel L, Shahar G, Margalit M. COVID-19-Related Economic Anxiety Is As High as Health Anxiety: Findings from the USA, the UK, and Israel. J Cogn Ther. 2020. https://doi.org/10.1007/s41811-020-00078-3
  17. McEwen BS, Sapolsky RM. Stress and cognitive function. Current Opinion in Neurobiology. 1995;5(2):205-216.  https://doi.org/10.1016/0959-4388(95)80028-X
  18. Vasileva AV. Pandemic and mental adjustment disorders: therapy options. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2020;120(5):146-152. (In Russ.). https://doi.org/10.17116/jnevro2020120051146
  19. Martyushev-Poklad AV, Voronina TA. Stress-limiting systems and neuronal plasticity in the pathogenesis of mental and neurological disorders. Obzory po klinicheskoj farmakologii i lekarstvennoj terapii. 2003;2(4):15-25. (In Russ.).
  20. Rationalnaya pharmacotherapia v psychiatricheskoi praktike. Pod. Red. Alexandrovsky Y.A., Neznanov N.G. M.: GEOTAR-Media; 2014. (In Russ.).
  21. Watanabe N, Churchill R, Furukawa TA. Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database of Systematic Reviews. 2009;1:CD005335. https://doi.org/10.1002/14651858.CD005335
  22. Garcia R. Neurobiology of fear and specific phobias. Learn Mem. 2017;24(9):462-471.  https://doi.org/10.1101/lm.044115.116
  23. Ronai Sh, Oros F, Bolla K. The use of grandaxine in out-patient setting. Venger Pharmacother. 1975;4-10. (In Russ.).
  24. Alexandorvsky YA, Avedisova AS, Pavlova MS. The vegetotropic effect of grandaxine in primary care neurotic disorders treatment . Therapevticheskii arkhiv. 1998;10:76-85. (In Russ.).
  25. Vein AM, Artemenko AP, Oknin VY, Pomorcev IV. Grandaxin efficacy in the psychovegetative disorders correction. Klinicheskaya medicina. 1999;6:41-45. (In Russ.).
  26. Vasileva AV, Karavaeva TA, Semiglazova TY. Specific of the psychopharmacotherapy in oncology patients with anxiety disorders. Voprosy oncologii. 2018;64(5):567-661. (In Russ.).
  27. Avedisova AS, Alexandrovsky YuA, Pavlova MS. The psychotropic drug treatment choice for the maladjustment disorders therapy in forced migrants. Rossiisky Psychiatricheskyi journal. 1998;4:7-10. (in Russ.).
  28. Santarone K, McKenney M, Elkbuli A. Preserving mental health and resilience in frontline healthcare workers during COVID-19. Am J Emerg Med. 2020;38(7):1530-1531. https://doi.org/10.1016/j.ajem.2020.04.030
  29. Zhu Z, Xu S, Wang H, Liu Z, Wu J, Li G, Miao J, Zhang C, Yang Y, Sun W, Zhu S, Fan Y, Hu J, Liu J, Wang W. COVID-19 in Wuhan: Immediate Psychological Impact on 5062. Health Workers. Cold Spring Harbor Laboratory Press, Yale. medRxiv 2020.02.20.  https://doi.org/10.1101/2020.02.20.20025338
  30. Kang L, Li Y, Hu S, Chen M,Yang C, Yang BX, Wang Y, Hu J, Lai J, Ma X, Chen J, Guan L, Wang G, Ma H, Liu Z. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. 2020;7(3):e14.  https://doi.org/10.1016/S2215-0366(20)30047-X
  31. Gautam M, Kaur M, Mahr G. COVID-19-Associated Psychiatric Symptoms in Health Care Workers: Viewpoint From Internal Medicine and Psychiatry Residents [published online ahead of print, 2020 Apr 20]. Psychosomatics. 2020. https://doi.org/10.1016/j.psym.2020.04.009
  32. Iqbal MR, Chaudhuri A. COVID-19: Results of a national survey of United Kingdom healthcare professionals’ perceptions of current management strategy-A cross-sectional questionnaire study. Int J Surg. 2020;79:156-161.  https://doi.org/10.1016/j.ijsu.2020.05.042
  33. Cordova MJ, Riba MB, Spiegel D. Post-traumatic stress disorder and cancer. The Lancet. Psychiatry. 2017;4(4):330-338.  https://doi.org/10.1016/S2215-0366(17)30014-7
  34. Davydow DS, Gifford JM, Desai SV, Needham DM, Bienvenu OJ. Posttraumatic stress disorder in general intensive care unit survivors: a systematic review. General Hospital Psychiatry. 2008;30(5):421-434.  https://doi.org/10.1016/j.genhosppsych.2008.05.006.
  35. Vasileva AV, Karavaeva TA, Lukoshkina EP, Veiss EE, Iakovleva IA. Breast cancer related PTSD in patients afer surgical treatment (mastectomy). Clinical and psychological issues. V.M. Bekhterev review of psychiatry and medical psychology. 2018;4:83-92. (In Russ.). https://doi.org/10.31363/2313-7053-2018-4-83-92
  36. Dutheil F, Mondillon L, Navel V. PTSD as the second tsunami of the SARS-Cov-2 pandemic. Psychological Medicine. 2020;1-2.  https://doi.org/10.1017/S0033291720001336
  37. Pandharipande PP, Ely EW, Arora RC, Balas MC, Boustani MA, La Calle GH, Cunningham C, Devlin JW, Elefante J, Han JH, MacLullich AM, Maldonado JR, Morandi A, Needham DM, Page VJ, Rose L, Salluh JIF, Sharshar T, Shehabi Y, Skrobik Y, Slooter AJC, Smith HAB. The intensive care delirium research agenda: a multinational, interprofessional perspective. Intensive Care Med. 2017;43(9):1329-1339. https://doi.org/10.1007/s00134-017-4860-7
  38. Hosseini AA, Shetty AK, Sprigg N, Auer DP, Constantinescu CS. Delirium as a presenting feature in COVID-19: Neuroinvasive infection or autoimmune encephalopathy? (published online ahead of print, 2020 Jun 9). Brain Behav Immun. 2020;88:68-70.  https://doi.org/10.1016/j.bbi.2020.06.012
  39. O’Hanlon S, Inouye SK. Delirium: a missing piece in the COVID-19 pandemic puzzle. Age Ageing. 2020;49(4):497-498.  https://doi.org/10.1093/ageing/afaa094
  40. Fekih-Romdhane F, Ghrissi F, Abbassi B, Cherif W, Cheour M. Prevalence and predictors of PTSD during the COVID-19 pandemic: Findings from a Tunisian community sample (published online ahead of print, 2020 May 27). Psychiatry Res. 2020;290:113131. https://doi.org/10.1016/j.psychres.2020.113131
  41. Forte G, Favieri F, Tambelli R, Casagrande M. COVID-19 Pandemic in the Italian Population: Validation of a Post-Traumatic Stress Disorder Questionnaire and Prevalence of PTSD Symptomatology. Int J Environ Res Public Health. 2020;17(11):4151. https://doi.org/10.3390/ijerph17114151
  42. Murray H, Grey N, Wild J, Warnock-Parkes E, Kerr A, Clark D, Ehlers A. Cognitive therapy for post-traumatic stress disorder following critical illness and intensive care unit admission. The Cognitive Behaviour Therapist. 2020;13:E13.  https://doi.org/10.1017/S1754470X2000015X
  43. Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham DM. Posttraumatic stress disorder in critical illness survivors: a meta-analysis. Critical Care Medicine. 2015;43:1121-1129.
  44. Paparrigopoulos T, Melissaki A, Tzavellas E, Karaiskos D, Ilias I, Kokras N. Increased co-morbidity of depression and post-traumatic stress disorder symptoms and common risk factors in intensive care unit survivors: a two year follow-up study. International Journal of Psychiatry in Clinical Practice. 2014;18:25-31. 
  45. Tilouche N, Hassen MF, Ali HBS, Jaoued O, Gharbi R, El Atrous SS. Delirium in the intensive care unit: Incidence, risk factors, and impact on outcome. Indian Journal of Critical Care Medicine. 2018;22:144-149.  https://doi.org/10.4103/ijccm.ijccm_244_17
  46. Vasil’eva AV, Karavaeva TA, Lukoshkina EP. Diagnostika i terapija posttravmaticheskogo stressovogo rasstrojstva v klinike pogranichnyh rasstrojstv i somaticheskoj medicine. Diagnostika i lechenie psihicheskih i narkologicheskih rasstrojstv: sovremennye podhody. Sbornik metodicheskih rekomendacij. Spb, 2019;2:300-323. (In Russ.).
  47. Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller H-J. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary. International journal of psychiatry in clinical practice. 2012;16:77-84.  https://doi.org/10.3109/13651501.2012.667114
  48. Carmassi C, Foghi C, Dell’Oste V, Cordone A, Bertelloni CA, Bui E, Dell’Osso L. PTSD symptoms in healthcare workers facing the three coronavirus outbreaks: What can we expect after the COVID-19 pandemic (published online ahead of print, 2020 Jul 20). Psychiatry Res. 2020;292:113312. https://doi.org/10.1016/j.psychres.2020.113312
  49. Walton M, Murray E, Christian MD. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic. Eur Heart J Acute Cardiovasc Care. 2020;9(3):241-247.  https://doi.org/10.1177/2048872620922795
  50. Nordt C, Warnke I, Seifritz E, Kawohl W. Modelling suicide and unemployment: a longitudinal analysis covering 63 countries, 2000-11. Lancet Psychiatry. 2015;2:239-245. 
  51. Kawohl W, Nordt C. COVID-19, unemployment, and suicide. Lancet Psychiatry. 2020;7(5):389-390.  https://doi.org/10.1016/S2215-0366(20)30141-3
  52. WHO Suicide prevention. https://www.who.int/health-topics/suicide#tab=tab_1
  53. Gunnell D, Appleby L, Arensman E, Hawton K, John A, Kapur N, Khan M, O’Connor RC, Pirkis J, Appleby L, Arensman E, Caine ED, Chan LF, Chang S-S, Chen Y-Y, Christensen H, Dandona R, Eddleston M, Erlangsen A, Gunnell D, Harkavy-Friedman J, Hawton K, John A, Kapur N, Khan M, Kirtley OJ, Knipe D, Konradsen F, Liu S, McManus S, Mehlum L, Miller M, Moran P, Morrissey J, Moutier C, Niederkrotenthaler T, Nordentoft M, O’Connor RC, O’Neill S, Page A, Phillips MR, Pirkis J, Platt S, Pompili M, Qin P, Rezaeian M, Silverman M, Sinyor M, Stack S, Townsend E, Turecki G, Vijayakumar L, Yip PSF. Suicide risk and prevention during the COVID-19 pandemic. Lancet Psychiatry. 2020;7(6):468-471.  https://doi.org/10.1016/S2215-0366(20)30171-1
  54. Thomas SP. Focus on Depression and Suicide in the Era of COVID-19. Issues Ment Health Nurs. 2020;41(7):559.  https://doi.org/10.1080/01612840.2020.1769435
  55. Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M, Coles JP, Manji H, Salman R A-S, Menon DK, Nicholson TR, Benjamin LA, Carson A, Smith C, Turner MR, Solomon T, Kneen R, Pett SL, Galea I, Thomas RH, Michael BD, Allen C, Archibald N, Arkell J, Arthur-Farraj P, Baker M, Ball H, Bradley-Barker V, Brown Z, Bruno S, Carey L, Carswell C, Chakrabarti A, Choulerton J, Daher M, Davies R, Barros RDM, Dima S, Dunley R, Dutta D, Ellis R, Everitt A, Fady J, Fearon P, Fisniku L, Gbinigie I, Gemski A, Gillies E, Gkrania-Klotsas E, Grigg J, Hamdalla H, Hubbett J, Hunter N, Huys A-C, Ihmoda I, Ispoglou S, Jha A, Joussi R, Kalladka D, Khalifeh H, Kooij S, Kumar G, Kyaw S, Li L, Littleton E, Macleod M, Macleod MJ, Madigan B, Mahadasa V, Manoharan M, Marigold R, Marks I, Matthews P, Mccormick M, Mcinnes C, Metastasio A, Milburn-McNulty P, Mitchell C, Mitchell D, Morgans C, Morris H, Morrow J, Mohamed AM, Mulvenna P, Murphy L, Namushi R, Newman E, Phillips W, Pinto A, Price DA, Proschel H, Quinn T, Ramsey D, Roffe C, Russell AR, Samarasekera N, Sawcer S, Sayed W, Sekaran L, Serra-Mestres J, Snowdon V, Strike G, Sun J, Tang C, Vrana M, Wade R, Wharton C, Wiblin L, Boubriak I, Herman K, Plant G. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study (published online ahead of print, 2020 Jun 25) (published correction appears in Lancet Psychiatry. 2020 Jul 14). Lancet Psychiatry. 2020. https://doi.org/10.1016/S2215-0366(20)30287-X
  56. Dinakaran D, Manjunatha N, Naveen Kumar C, Suresh BM. Neuropsychiatric aspects of COVID-19 pandemic: A selective review (published online ahead of print, 2020 May 30). Asian J Psychiatr. 2020;53:102188. https://doi.org/10.1016/j.ajp.2020.102188
  57. Giljarovskij VA. Psihiatrija. M: Medgiz, 1954;520. (In Russ.).
  58. Pinto EF, Andrade C. Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem. Curr Neuropharmacol. 2016;14(7):743-748.  https://doi.org/10.2174/1570159x14666160106155129
  59. Raison CL, Borisov AS, Broadwell SD, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, Miller AH. Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry. 2005;66(1):41-48.  https://doi.org/10.4088/jcp.v66n0106
  60. Pretorius E. Corticosteroids, depression and the role of serotonin. Rev Neurosci. 2004;15(2):109-116.  https://doi.org/10.1515/revneuro.2004.15.2.109
  61. García CAC, Sánchez EBA, Huerta DH, Gómez-Arnau J. Covid-19 treatment-induced neuropsychiatric adverse effects (published online ahead of print, 2020 Jun 10). Gen Hosp Psychiatry. 2020. https://doi.org/10.1016/j.genhosppsych.2020.06.001
  62. Costello H, Gould RL, Abrol E, Howard R. Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open. 2019;9(7):e027925. https://doi.org/10.1136/bmjopen-2018-027925
  63. Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J, Salum G, Magalhães PV, Kapczinski F, Kauer-Sant’Anna M. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015;2(11):1002-1012. https://doi.org/10.1016/S2215-0366(15)00309-0
  64. Connor TJ, Kelliher P, Shen Y, Harkin A, Kelly JP, Leonard BE. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacol Biochem Behav. 2000;65:591-597.  https://doi.org/10.1016/s0091-3057(99)00192-6
  65. Neznanov NG, Mazo GE., Rukavishnikov GV, Kibitov AO. Depression as a predictor of somatic disorders: pathological premises and genetic risks. Uspehi fiziologicheskih nauk. 2017;48(4):29-39. (In Russ.).
  66. Neznanov NG, Kibitov AO, Rukavishnikov GV, Mazo GE. The prognostic role of depression as a predictor of chronic somatic diseases manifestation. Terapevticheskij arhiv. 2018;90(12):122-132. (In Russ.).
  67. Krause D, Kirnich V, Stapf T, Hennings A, Riemer S, Riedel M, Schmidmaier R, Gil F, Rief W, Schwarz M. Values of Cytokines and Tryptophan Metabolites over a 12 Weeks Time Course in Patients with Depression and Somatoform Disorder. Clinical Psychopharmacology and Neuroscience. 2019;17:34-42.  https://doi.org/10.9758/cpn.2019.17.1.34
  68. Miller AH, Haroon E, Raison CL, Felger JC. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety. 2013;30(4):297-306.  https://doi.org/10.1002/da.22084
  69. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65:732-7419.
  70. Shipilov MV. Molecular Mechanisms of Cytokine Storm in Acute Infectious Diseases. (In Russ.). https://cyberleninka.ru/article/n/molekulyarnye-mehanizmy-tsitokinovogo-shtorma-pri-ostryh-infektsionnyh-zabolevaniyah
  71. Rukavishnikov GV, Mazo GE, Neznanov NG, Kibitov AO. Genetic and epigenetic aspects of depression and somatic disorders comorbidity on and somatic disorders comorbidity. V.M. Bekhterev review of psychiatry and medical psychology. 2019;4-1:78-79. (In Russ.). https://doi.org/10.31363/2313-7053-2019-4-1-78-79
  72. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect. 2020;80(6):607-613.  https://doi.org/10.1016/j.jinf.2020.03.037
  73. Mayorova MA, Petrova NN, Stroev UI, Churilov LP, Shoenfeld Y. Interrelation of auto-immune process, endocrine disorders and depression. V.M. Bekhterev review of psychiatry and medical psychology. 2020;1:8-19. (In Russ.). https://doi.org/10.31363/2313-7053-2020-1-8-19
  74. Debnath M, Berk M, Maes M. Changing dynamics of psychoneuroimmunology during the COVID-19 pandemic. Brain Behav Immun Health. 2020;5:100096. https://doi.org/10.1016/j.bbih.2020.100096
  75. Conti G, Ronconi A, Caraffa CE, Gallenga R, Ross I, Frydas SK. Kritas Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies (Epub ahead of print). J Biol Regul Homeost Agents. 2020;34. 
  76. Vasil’eva AV, Neznanov NG. Psihoterapija (Psihiatrija: nacional’noe rukovodstvo) gl. red. Ju.A. Aleksandrovskij, N.G. Neznanov. 2-e izd., pererab. i dop. M. : GJeOTAR-Media, 2018. - 1008s. - Gl.31. - S. 915-952. (In Russ.).
  77. Klinicheskaya psychotherapiya v obschei vrachebnoi praktike. Pod. red. Neznanov NG, Karvassarsky BD. SPb.: Piter; 2008. (In Russ.).
  78. Roberts AR. Crisis intervention handbook: assessment, treatment, and research, 3rd edn. Oxford: Oxford University Press, 2005.
  79. Leahey R. Svoboda ot trevogi. SPb.: Piter; 2017. (In Russ.).
  80. Duan L, Zhu G. Psychological interventions for people affected by the COVID-19 epidemic. The Lancet Psychiatry. 2020;7. Accessed on 17 April, 2020. https://doi.org/10.1016/S2215-0366(20)30073-0
  81. Mosolov SN. Problems of mental health in the situation of covid-19 pandemic. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2020;120(5):7-15. (In Russ.). https://doi.org/10.17116/jnevro20201200517
  82. Bäuerle A, Graf J, Jansen C, Dörrie N, Junne F, Teufel M, Skoda E-M. An e-mental health intervention to support burdened people in times of the COVID-19 pandemic: CoPE It. Journal of Public Health. 2020;42(3):647-648.  https://doi.org/10.1093/pubmed/fdaa058
  83. Kwon CY, Kwak HY, Kim JW. Using Mind-Body Modalities via Telemedicine during the COVID-19 Crisis: Cases in the Republic of Korea. Int J Environ Res Public Health. 2020;17(12):4477. https://doi.org/10.3390/ijerph17124477
  84. Wind TR, Rijkeboer M, Andersson G, Riper H. The COVID-19 pandemic: The «black swan» for mental health care and a turning point for e-health. Internet Interv. 2020;20:100317. https://doi.org/10.1016/j.invent.2020.100317
  85. Ransing R, Adiukwu F, Pereira-Sanchez V, Ramalho R, Orsolini L, Teixeira ALS, Gonzalez-Diaz JM, da Costa MP, Soler-Vidal J, Bytyçi DG, Hayek SE, Larnaout A, Shalbafan M, Syarif Z, Nofal M, Kundadak GK. Mental Health Interventions during the COVID-19 Pandemic: A Conceptual Framework by Early Career Psychiatrists. Asian J Psychiatr. 2020;51:102085. https://doi.org/10.1016/j.ajp.2020.102085
  86. Sanderson WC, Arunagiri V, Funk AP, Ginsburg KL, Krychiw JK, Limowski AR, Olesnycky OS, Stout Z. The Nature and Treatment of Pandemic-Related Psychological Distress (published online ahead of print, 2020 Jun 27). J Contemp Psychother. 2020;1-13.  https://doi.org/10.1007/s10879-020-09463-7
  87. Behan C. The benefits of meditation and mindfulness practices during times of crisis such as COVID-19 (published online ahead of print, 2020 May 14). Ir J Psychol Med. 2020;1-3.  https://doi.org/10.1017/ipm.2020.38
  88. Reyes AT. A Mindfulness Mobile App for Traumatized COVID-19 Healthcare Workers and Recovered Patients: A Response to «The Use of Digital Applications and COVID-19». Community Ment Health J. 2020;56:1204-1205. https://doi.org/10.1007/s10597-020-00690-9
  89. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry. 2001;178:234-241.  https://doi.org/10.1192/bjp.178.3.234
  90. Mosolov SN, Kostyukova EG, Gorodnichev AV, Timofeev IV, Ladyzhensky MYa, Serditov OV. Clinical efficacy and tolerability of venlafaxine (Velaxin) in the treatment of moderate to severe depression. Trudnyj pacient. 2007;11:72-78. (In Russ.).
  91. Smith D, Dempster C, Glanville J, Freemantle N, Anderson I. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry. 2002;180:396-404.  https://doi.org/10.1192/bjp.180.5.396
  92. Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME. Comprehensive analysis of remission with venlafaxine versus SSRI. Biol Psychiatr. 2008;63:424-434.  https://doi.org/10.1016/j.biopsych.2007.06.027
  93. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366. https://doi.org/10.1016/S0140-6736(17)32802-7
  94. Panteleeva GP, Oleĭchik IV, Abramova LI, Iumatova PE. Treatment of endogenous depression with venflaxine: clinical action, tolerability and personalized treatment options. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2015;115(1 vyp 2):43-51. (In Russ.). https://doi.org/10.17116/jnevro20151152243-51
  95. Avedisova AS. Venlafaxin (velaxin): results of international studies of anti-depressant, iii generation. Psychiatry and psychopharmacotherapy. 2006;8(2)33-38. (In Russ.).
  96. Lyndon GJ, Prieto R, Wajsbrot DB, Allgulander C, Bandelow B. Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity. Int Clin Psychopharmacol. 2019;34(3):110-118.  https://doi.org/10.1097/YIC.0000000000000256

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.